-
News
01.11.2009
Smoking increases the risk of skin psoriasisA new research regarding the interaction between smoking and the skin condition psoriasis shows that smoking increases the risk of contracting the...
Read more29.10.2009
Smoking increase the risk of tuberculosisThe harmful influence of smoking on our organism is well known, but new studies show that it can double your chances of catching active tuberculosis....
Read more
-
Powered By: Crafty Syntax
-
Zyban (Glaxowellcome)
Zyban is a medication designed to help smokers quit more easily the harmful habit of smoking. It comes in a pill form. It also does not contain nicotine. Smokers who happened to be users of the anti-depression medication Wellbutrin (bupropion hydrochloride) often reported a lessening in the desire for cigarettes. These two medications are similar. Through further testing, the drug was found to be effective in treating the smoking addiction, and helping smokers quit.
Zyban approximately doubles the chance of quitting smoking successfully after three months. One year after the treatment, the odds of sustaining smoking cessation are still 1.5 times higher in the bupropion group than in the placebo group.-
Zyban (Glaxowellcome)
Zyban's history is interesting. Smokers who used the anti-depression medication Wellbutrin (bupropion hydrochloride) often reported a certain change in their attitude towards the desire for cigarettes. Through further testing, the drug was found to be effective in treating the smoking addiction, and helping to quit smoking. Zyban reduces the severity of nicotine cravings and withdrawal symptoms. The bupropion treatment course lasts for seven to twelve weeks, with the patient halting the use of tobacco about ten days into the course. The efficacy of bupropion is similar to that of nicotine replacement therapy.
Zyban prevents two of these neurotransmitters, noradrenaline and dopamine, from being reabsorbed back into the nerve cells. Noradrenaline and dopamine are responsible for moderating mood and various other processes in the brain. It is thought that bupropion helps people to quit smoking by increasing the amount of noradrenaline and dopamine free to act in the brain. Bupropion prevents two of these neurotransmitters, noradrenaline and dopamine, from being reabsorbed back into the nerve cells. Noradrenaline and dopamine are responsible for moderating mood and various other processes in the brain. It is thought that bupropion helps people to quit smoking by increasing the amount of noradrenaline and dopamine free to act in the brain. Unlike nicotine patches or nicotine gum, Zyban does not contains nicotine and have a different method for quit smoking support. In case of Zyban, you continue to smoke when you start taking the medication, eventually reaching an established date you planned to quit and you continue to take the drug for a period of time after quitting smoking cigarettes.
Even if you buy Zyban in stores or online Zyban reduces the severity of nicotine cravings and withdrawal symptoms. The efficacy of this medication is similar to that of nicotine replacement therapy. While taking Zyban, smokers want to know what it will do to make the quitting process easier. Zyban has the capacity to avoid the withdrawal symptoms and to help you finally get rid of cigarettes.
Before taking this drug, smokers want to know what it will do to make quitting smoking easier. According to the results reported during clinical trials, "treatment with Zyban reduced withdrawal symptoms compared to placebo. Zyban is not without side-effects. According the the Zyban website, "The most common side effects experienced with this medication include dry mouth and difficulty sleeping. There are other risks associated with the use of Zyban, so it is important to talk to your healthcare professional to see whether Zyban is right for you. There is a risk of seizure associated with Zyban, which is increased in certain patients." It has proven more effective than placebo in clinical testing, with success rates ranging as high as 58% in one study. Most studies showed success rates at somewhere between 15%-25%. Long-term success rates are obviously on the lower end, as smokers tend to relapse after longer periods of time. -